Cargando…
Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico
Healthcare-associated adverse events represent a heavy burden of symptoms for pediatric oncology patients. Their description allows knowing the safety and quality of the care processes in countries with limited resources. This study aimed to describe the incidence, types, severity, and preventabilit...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947076/ https://www.ncbi.nlm.nih.gov/pubmed/35324939 http://dx.doi.org/10.1371/journal.pone.0265450 |
_version_ | 1784674352927604736 |
---|---|
author | Vázquez-Cornejo, Edmundo Morales-Ríos, Olga Hernández-Pliego, Gabriela Cicero-Oneto, Carlo Garduño-Espinosa, Juan |
author_facet | Vázquez-Cornejo, Edmundo Morales-Ríos, Olga Hernández-Pliego, Gabriela Cicero-Oneto, Carlo Garduño-Espinosa, Juan |
author_sort | Vázquez-Cornejo, Edmundo |
collection | PubMed |
description | Healthcare-associated adverse events represent a heavy burden of symptoms for pediatric oncology patients. Their description allows knowing the safety and quality of the care processes in countries with limited resources. This study aimed to describe the incidence, types, severity, and preventability of adverse events occurring in pediatric patients with acute lymphoblastic leukemia during the induction phase in a tertiary care pediatric hospital in Mexico. This study analyzed a cohort based on medical records of between 2015 and 2017. Initially, information on patients and adverse events was collected; subsequently, two pediatric oncologist reviewers independently classified adverse events, severity and preventability. Agreement between reviewers was evaluated. Adverse events incidence rates were estimated by type, severity, and preventability. One-hundred and eighty-one pediatric patients pediatric patients with acute lymphoblastic leukemia were studied. An overall adverse events rate of 51.8 per 1000 patient-days was estimated, involving 81.2% of patients during induction. Most adverse events were severe or higher (52.6%). Infectious processes were the most common severe or higher adverse event (30.5%). The presence of adverse events caused 80.2% of hospital readmissions. Of the adverse events, 10.5% were considered preventable and 53.6% could be ameliorable in severity. Improving the safety and quality of the care processes of children with acute lymphoblastic leukemia is possible, and this should contribute to the mitigation and prevention of adverse events associated morbidity and mortality during the remission induction phase. |
format | Online Article Text |
id | pubmed-8947076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-89470762022-03-25 Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico Vázquez-Cornejo, Edmundo Morales-Ríos, Olga Hernández-Pliego, Gabriela Cicero-Oneto, Carlo Garduño-Espinosa, Juan PLoS One Research Article Healthcare-associated adverse events represent a heavy burden of symptoms for pediatric oncology patients. Their description allows knowing the safety and quality of the care processes in countries with limited resources. This study aimed to describe the incidence, types, severity, and preventability of adverse events occurring in pediatric patients with acute lymphoblastic leukemia during the induction phase in a tertiary care pediatric hospital in Mexico. This study analyzed a cohort based on medical records of between 2015 and 2017. Initially, information on patients and adverse events was collected; subsequently, two pediatric oncologist reviewers independently classified adverse events, severity and preventability. Agreement between reviewers was evaluated. Adverse events incidence rates were estimated by type, severity, and preventability. One-hundred and eighty-one pediatric patients pediatric patients with acute lymphoblastic leukemia were studied. An overall adverse events rate of 51.8 per 1000 patient-days was estimated, involving 81.2% of patients during induction. Most adverse events were severe or higher (52.6%). Infectious processes were the most common severe or higher adverse event (30.5%). The presence of adverse events caused 80.2% of hospital readmissions. Of the adverse events, 10.5% were considered preventable and 53.6% could be ameliorable in severity. Improving the safety and quality of the care processes of children with acute lymphoblastic leukemia is possible, and this should contribute to the mitigation and prevention of adverse events associated morbidity and mortality during the remission induction phase. Public Library of Science 2022-03-24 /pmc/articles/PMC8947076/ /pubmed/35324939 http://dx.doi.org/10.1371/journal.pone.0265450 Text en © 2022 Vázquez-Cornejo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Vázquez-Cornejo, Edmundo Morales-Ríos, Olga Hernández-Pliego, Gabriela Cicero-Oneto, Carlo Garduño-Espinosa, Juan Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico |
title | Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico |
title_full | Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico |
title_fullStr | Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico |
title_full_unstemmed | Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico |
title_short | Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico |
title_sort | incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in mexico |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947076/ https://www.ncbi.nlm.nih.gov/pubmed/35324939 http://dx.doi.org/10.1371/journal.pone.0265450 |
work_keys_str_mv | AT vazquezcornejoedmundo incidenceseverityandpreventabilityofadverseeventsduringtheinductionofpatientswithacutelymphoblasticleukemiainatertiarycarepediatrichospitalinmexico AT moralesriosolga incidenceseverityandpreventabilityofadverseeventsduringtheinductionofpatientswithacutelymphoblasticleukemiainatertiarycarepediatrichospitalinmexico AT hernandezpliegogabriela incidenceseverityandpreventabilityofadverseeventsduringtheinductionofpatientswithacutelymphoblasticleukemiainatertiarycarepediatrichospitalinmexico AT ciceroonetocarlo incidenceseverityandpreventabilityofadverseeventsduringtheinductionofpatientswithacutelymphoblasticleukemiainatertiarycarepediatrichospitalinmexico AT gardunoespinosajuan incidenceseverityandpreventabilityofadverseeventsduringtheinductionofpatientswithacutelymphoblasticleukemiainatertiarycarepediatrichospitalinmexico |